Clawbacks for the 2024 hospital pharmaceutical budget came in marginally lower than 2023’s critical levels, remaining at an ...

Recent partnership announcements in the pharma industry reflects the community’s commitment to collaborative innovation, ...

Mochida Pharmaceutical (TSE:4534) reported a net profit margin of 5.7%, up from 4.3% a year earlier, with earnings surging 36.5% over the past year. Despite this progress, shares currently trade at ¥3 ...

In today’s Pharmaceutical Executive Daily, we cover Kimberly-Clark’s $48.7 billion acquisition of Kenvue, Cencora’s $1 ...

Agentic AI was a point of emphasis on the first day of the 2025 Veeva Commercial summit held in Madrid, Spain.

Tariffs increase operational costs by raising prices for raw materials, APIs, and finished drugs, complicating logistics and ...

Ensuring fair drug pricing was a key promise of Sri Lanka’s government’s election manifesto, and that promise is finally ...

Terns Pharmaceuticals (TERN) is getting attention after announcing that early-stage trial results for its CML drug candidate, TERN-701, were selected for oral presentation at this year's American ...

The newly established division aims to produce 22mln units annually of cancer and immunosuppressive drugs that meet EU-GMP ...

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your ...

Indore (Madhya Pradesh): Under the World Bank-supported ‘RAMP (Raising and Accelerating MSMEs Performance)’ scheme, the ...

Sun Pharma is open to expanding its US manufacturing capabilities in response to the Trump administration's 100% tariff on ...